DaShenLin Pharmaceutical Group Co., Ltd.
SHH: 603233.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Guoqiang Ke
- Employees
- 43,532
- Headquarters
- Guangzhou, China
- IPO year
- 2017
- Market cap
- CN¥21.1B
- Website
- https://www.dslyy.com
Loading 603233…
Loading profile data…Frequently asked questions about 603233
What does DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS) do?
DaShenLin Pharmaceutical Group Co., Ltd. manufactures, wholesales, and retails pharmaceutical products in China. The company was founded in 1999 and is based in Guangzhou, China.
Where does 603233.SS trade?
DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS) trades on the Shanghai Stock Exchange.
What sector is 603233.SS in?
DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of DaShenLin Pharmaceutical Group Co., Ltd.?
Guoqiang Ke is the chief executive officer of DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS).
Where is DaShenLin Pharmaceutical Group Co., Ltd. headquartered?
DaShenLin Pharmaceutical Group Co., Ltd. is headquartered in China.
Does 603233.SS pay a dividend?
Yes — DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS) paid a trailing twelve-month dividend of CNY 0.65 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 603233.SS go public?
DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS) completed its initial public offering in 2017.